First reported at 400,000 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-06-30 | 29984000 |
| 2022-09-30 | 38689000 |
| 2022-12-31 | 28507600 |
| 2023-03-31 | 30322600 |
| 2023-06-30 | 34356000 |
| 2023-09-30 | 24244000 |
| 2023-12-31 | 0 |
| 2024-03-31 | 51784000 |
| 2024-06-30 | 23700000 |
| 2024-09-30 | 18733500 |
| 2024-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2024 | Reduced | 0 | -150,000 (-100.0%) | 0 | $0 | 2025-02-14 | |
| Q3 2024 | Unchanged | 150,000 | 0 (0.0%) | 2.02% | $18,733,500 | 2024-11-14 | |
| Q2 2024 | Reduced | 150,000 | -250,000 (-62.5%) | 1.91% | $23,700,000 | 2024-08-14 | |
| Q1 2024 | New | 400,000 | +400,000 (0.0%) | 4.19% | $51,784,000 | 2024-05-15 | |
| Q4 2023 | Reduced | 0 | -200,000 (-100.0%) | 0 | $0 | 2024-02-14 | |
| Q3 2023 | Reduced | 200,000 | -100,000 (-33.3%) | 3.23% | $24,244,000 | 2023-11-14 | |
| Q2 2023 | Added | 300,000 | +80,000 (36.4%) | 4.67% | $34,356,000 | 2023-08-14 | |
| Q1 2023 | Unchanged | 220,000 | 0 (0.0%) | 4.34% | $30,322,600 | 2023-05-15 | |
| Q4 2022 | Reduced | 220,000 | -130,000 (-37.1%) | 3.34% | $28,507,600 | 2023-02-14 | |
| Q3 2022 | Reduced | 350,000 | -50,000 (-12.5%) | 4.76% | $38,689,000 | 2022-11-14 | |
| Q2 2022 | New | 400,000 | +400,000 (0.0%) | 5.5% | $29,984,000 | 2022-08-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
354 managers reported SAREPTA THERAPEUTICS INC COM S for Q2 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | Added | 8,420,047 | +104,865 | 0.02% | $631,166,000 | 37 qtrs |
| JANUS HENDERSON GROUP PLC | Reduced | 7,232,672 | -225,910 | 0.37% | $542,171,000 | 17 qtrs |
| BlackRock Inc | Added | 5,607,663 | +60,704 | 0.01% | $420,352,000 | 37 qtrs |
| SANDS CAPITAL MANAGEMENT LLC | Reduced | 3,711,101 | -1,071,850 | 0.96% | $278,184,000 | 16 qtrs |
| Avoro Capital Advisors LLC | Added | 3,390,000 | +255,000 | 5.02% | $254,114,000 | 17 qtrs |
| EcoR1 Capital LLC | Added | 2,868,145 | +798,511 | 7.42% | $214,996,000 | 2 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Added | 2,768,861 | +88,383 | 0.04% | $207,553,000 | 18 qtrs |
| STATE STREET CORPORATION | Added | 2,316,483 | +258,808 | 0.01% | $173,644,000 | 37 qtrs |
| THE BANK OF NEW YORK MELLON CORPORATION | Added | 1,990,927 | +16,104 | 0.03% | $149,238,000 | 37 qtrs |
| Camber Capital Management LP | Added | 1,850,000 | +475,000 | 6.02% | $138,676,000 | 4 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2022
- Filed
- August 15, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 400,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.